What Kotak Mid Cap Fund Bought and Sold in September 2026

Kotak Mid Cap Fund's holdings as of 30 September 2026 show an estimated ₹297.7 crore of buying in Dixon Technologies (India), the largest estimated addition of the month. The fund took four new positions and sold out of two stocks. It held 70 stocks at month-end, against 68 at 31 August 2026.
Biggest buys by Kotak Mid Cap Fund
Dixon Technologies (India) was the largest estimated buy, and its weight rose from 2.11% to 2.44% of the portfolio. Five stocks lead the list of estimated buying, and Fortis Healthcare and Metro Brands were close in size, at an estimated ₹158.9 crore and ₹158.8 crore.
| Stock | Estimated buying (₹ crore) | Weight (%) | Weight at 31 August 2026 (%) |
|---|---|---|---|
| Dixon Technologies (India) | 297.7 | 2.44 | 2.11 |
| Fortis Healthcare | 158.9 | 3.49 | 3.58 |
| Metro Brands | 158.8 | 1.29 | 1.07 |
| L&T Finance | 126.1 | 2.71 | 2.86 |
| Max Healthcare Institute | 86.5 | 1.01 | 0.92 |
Data as of 30 September 2026, compared with 31 August 2026. Values are estimates: change in shares × month-end price.
Estimates. Data as of 30 September 2026.
Four new stocks entered the portfolio
Gland Pharma was the largest new position, at 1.6% of the portfolio and an estimated ₹1,062.9 crore. Avalon Technologies and Molbio Diagnostics were smaller positions, at 0.83% and 0.54%. The fund did not hold any of these four stocks at 31 August 2026.
| Stock | Weight (%) | Estimated buying (₹ crore) |
|---|---|---|
| Gland Pharma | 1.6 | 1,062.9 |
| Avalon Technologies | 0.83 | 551.6 |
| Molbio Diagnostics | 0.54 | 359.9 |
| Aditya Infotech | 0.34 | 227.0 |
Data as of 30 September 2026, compared with 31 August 2026. Values are estimates: change in shares × month-end price.
Two stocks were sold out completely
The fund sold out of Power Finance Corporation and BSE in September. Power Finance Corporation was 0.69% of the portfolio at 31 August 2026, and BSE was 0.58%. Neither stock was held at the end of September.
Largest cuts without a full exit
Lenskart Solutions was the largest estimated reduction, at an estimated ₹137.0 crore, and Apar Industries followed at ₹124.3 crore. A weight can rise in a month when the fund sold shares, if the stock's price also rose. Blue Star and JK Cement show this pattern in the table below.
| Stock | Estimated selling (₹ crore) | Weight (%) | Weight at 31 August 2026 (%) |
|---|---|---|---|
| Lenskart Solutions | 137.0 | 0.84 | 0.95 |
| Apar Industries | 124.3 | 1.34 | 1.45 |
| PI Industries | 61.8 | 0.99 | 1.03 |
| Blue Star | 38.1 | 1.15 | 1.09 |
| JK Cement | 8.7 | 1.08 | 1.03 |
Data as of 30 September 2026, compared with 31 August 2026. Values are estimates: change in shares × month-end price. Weights are month-end values, so they can move with prices as well as with trades.
The portfolio at month-end
Fund assets were ₹66,613 crore at 30 September 2026, against ₹71,256 crore at 31 August 2026. The ten largest holdings made up 27.75% of the portfolio, and the fund's reported turnover was 29.5% over the trailing 12 months. Finance was the largest sector at 10.08%, followed by Pharmaceuticals and Biotechnology at 9.62% and Healthcare Services at 8.67%. Cash and equivalents were 1.85%, and overseas equity was 0.0%.
| Stock | Weight (%) | Weight at 31 August 2026 (%) |
|---|---|---|
| Ipca Laboratories | 3.57 | 3.42 |
| Fortis Healthcare | 3.49 | 3.58 |
| Vishal Mega Mart | 3.04 | 3.11 |
| L&T Finance | 2.71 | 2.86 |
| The Federal Bank | 2.62 | 2.76 |
Data as of 30 September 2026, compared with 31 August 2026. Weights are shares of the portfolio at each month-end. Ipca Laboratories was the largest holding at 3.57%, up from 3.42%. For the wider picture, see what mid cap funds bought in September 2026.
Reading this monthly snapshot
Holdings are disclosed once a month, so this view captures the start and end of the month, not the trades made in between. Rupee values are estimates: the change in shares multiplied by the month-end price, as funds do not disclose the prices they paid or received. A monthly snapshot can miss trades that were made and reversed within the month. A fund buying a stock is one manager's decision, sized for that portfolio. New to the category? Start with what is a mid cap fund.
Frequently asked questions
Which stocks did Kotak Mid Cap Fund buy in September 2026?
The largest estimated buys were Dixon Technologies (India) at ₹297.7 crore, Fortis Healthcare at ₹158.9 crore, Metro Brands at ₹158.8 crore, L&T Finance at ₹126.1 crore and Max Healthcare Institute at ₹86.5 crore. The fund also took new positions in Gland Pharma, Avalon Technologies, Molbio Diagnostics and Aditya Infotech. All values are estimates, calculated as the change in shares times the month-end price.
Which stocks did Kotak Mid Cap Fund sell out of in September 2026?
The fund sold out of two stocks in September 2026: Power Finance Corporation, which was 0.69% of the portfolio at 31 August 2026, and BSE, which was 0.58%. The largest estimated reduction without a full exit was Lenskart Solutions, at an estimated ₹137.0 crore. These are estimates based on the change in shares and month-end prices.
Where can I see a mutual fund's holdings?
Fund houses publish their monthly portfolios on their websites within 10 days of month-end, as SEBI requires. For Kotak Mid Cap Fund, the September 2026 holdings are as of 30 September 2026 and are compared with 31 August 2026 in this article. Check the scheme's page on the fund house website for the latest monthly portfolio.
Disclaimer
Mutual Fund investments are subject to market risks, read all scheme related documents carefully.
The funds on this page are shown for information and education, with figures as of 30 September 2026. Past performance does not indicate future returns. This is not personalised investment advice or a recommendation to buy or sell any fund, so check that a fund suits your own goals, time horizon and risk appetite, or speak to an adviser, before you invest.
Registration granted by SEBI, membership of BASL and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.
Blacklitt Technologies Private Limited · SEBI RIA INA000022428 · BSE enlistment 2491


